Center on Health Equity & Access

Clinical

Health Care Cost

Health Care Delivery

Insurance

Policy

Technology

Value-Based Care

News

All News

Press Releases

Product Approvals and Launches

Video

All Video Types

AJMC TV

Insights

OnLocation

Payer Perspectives

Peer Exchange

Post Conference Perspectives

Stakeholder Summit

Podcasts

Conferences

Conference Coverage

Conference Listing

Journals

All Journals

The American Journal of Managed Care

Population Health, Equity & Outcomes

Evidence-Based Oncology

About Supplements and Featured Publications

Supplements and Featured Publications Issues

Submit a Manuscript

Events

Institute for Value-Based Medicine

Patient-Centered Oncology Care

Resources

Interactive Tools

Clinical Spotlight

Microsites

About AJMC

AJMC Staff

Anniversary

Seema Sonnad Award

Strategic Alliance Partners

Subscribe

Maggie is an editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.

She has a BA in English from Penn State University. You can connect with Maggie on 

Articles

In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent in treating adolescents who have the myasthenia gravis and how nipocalimab works via FcRn blockade to reduce the circulating autoantibodies that drive myasthenia gravis.

How FcRn Blockade Targets Myasthenia Gravis Autoantibodies

Sen. Bill Cassidy, MD, (R, Louisiana) holds a key vote on Robert F. Kennedy Jr's HHS Secretary confirmation. When Cassidy asked for a strategy on Medicare and Medicaid, Kennedy could not provide one.

RFK Jr Fails to Offer a Clear Medicaid, Medicare Strategy

 in 2023, where she produces written content covering multiple disease states.

She has a BA in journalism from Seton Hall University. You can connect with Brooke on 

Although long-term nursing home stay or death decreased before the COVID-19 pandemic, the trend slowed during the pandemic across all racial and ethnic groups.

COVID-19 Pandemic Increased Long-Term Nursing Home Stay or Death Across All Groups

The design of the Enhancing Oncology Model (EOM) was a perfect fit for Minnesota Oncology. 

Embracing EOM, Enhancing Collaboration and Cost Management: Dr Kirollos Hanna

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

About

Contact

Editorial Boards

Advertise

Do Not Sell My Information

Terms & Conditions

Privacy Policy

AJMC - Managed Care News, Research, and Expert Insights

Facebook

Twitter

LinkedIn

Instagram

Specialty Area

Biosimilars

Cardiorenalmetabolic

Dermatology

Gastroenterology

Hematology

Hepatology

Immunology

Infectious Disease

MASH

Mental Health

Neurology

Obesity

Oncology

Ophthalmology

Pulmonology

Rare Disease

Respiratory

Rheumatology

Women's Health

Spotlight

Free In-Person Regional Events Focused on Oncology and Population Health

Topics

Digital Health

Formulary

Gene Therapy

Guidelines

Health Care Administration

Population Health

All Coverage

Event Coverage

Interviews

AJMC Journals

Author Forms

Authors

Nominate a Rising Leader

AJMC® Peer Exchange® peer-to-peer panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today’s managed care professionals.

Managed Care Consideration for an Emerging Class of Therapy in Anemia of Chronic Kidney Disease

Videos

Overview of Chronic Kidney Disease

Role of Anemia in CKD

Payer Perspective of Anemia in CKD

Treatment of Anemia in CKD

Standard of Care: Therapeutic Options for Anemia in CKD

Anemia in CKD: CHOIR and TREAT Trials

Economic Burden of Anemia in CKD

Treatment of Anemia in CKD During COVID-19

HIF Stabilizers for Anemia in CKD: Phase 3 Trials

HIMALAYAS Trial: Long-Term Cardiovascular Safety Data

HIF Stabilizers: Management of Anemia in CKD

Payer Perspective of HIF Stabilizers for Anemia in CKD

Anemia in CKD: HIF Stabilizers in Clinical Trials

Future Treatment of Anemia in CKD: Impact of HIF Stabilizers

Future Management of Anemia in CKD